Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/05/019293
CTRI/2019/05/019293
Recruiting
未知

ââ?¬Å?Magnesium sulfate ( MAGSALF) for fetal neuroprotection given in spontaneous preterm birth versus magnesium sulfate for hypertensive disorder of pregnancy versus preterm newborn not receiving magsalf ââ?¬â?? A comparative prospective cohort study

King Georges Medical University0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: O368- Maternal care for other specifiedfetal problems

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O368- Maternal care for other specifiedfetal problems
Sponsor
King Georges Medical University
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
King Georges Medical University

Eligibility Criteria

Inclusion Criteria

  • •Women with established preterm labour (regular uterine contraction with cervical dilatation of ââ?°Â¥4 cm )at gestational age of less than 32 weeks.
  • •2\. Women requiring iatrogenic preterm labour / cesarean at gestatonal age less than 32 weeks
  • •3\. Women with severe pre\-Eclampsia or Eclampsia having preterm labour being given magnesium sulphate at less than 32 weeks .

Exclusion Criteria

  • •1\.Myasthenia gravis
  • •2\.Acute renal failure
  • •3\.False preterm
  • •4\.Gestational age more than 32 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Antenatal magnesium sulphate for protection of the preterm brain in women at risk preterm delivery at 28-36 weeks gestatioNervous System Diseases
PACTR202404671084461Dr Linda James Audu90
Active, not recruiting
Phase 2
Magnesium sulfate as an adjuvant therapy in neonatal hypoxianeonatal hypoxiahypoxic ischemic encephalopathy S100&#45b magnesium sulfate neonates
TCTR20180720002Tanta university hospital60
Not yet recruiting
Not Applicable
Role of Magnesium suplhate to mother in protecting brain of preterm babiesHealth Condition 1: null- Preterm infants
CTRI/2018/06/014386PGIMS
Active, not recruiting
Phase 1
Does magnesium sulphate prevent cerebral palsy in very preterm born infants?
EUCTR2011-000735-80-DKene Drasbek Huusom560
Unknown
Not Applicable
Magnesium Sulfate for Fetal NeuroprotectionFetal Neuroprotection
NCT04401852Cairo University200